cardiovascular outcomes glp-1 news today Risks after Discontinuation Cardiovascular outcomes of semaglutide and

Using a global dataset and propensity matching, they found significantly lower mortality rates, major cardiovascular events (MACEs), and adverse kidney outcomes (MAKEs) among GLP-1 RA users compared to non-users

A new study shows the medications could have a broader effect on addiction.

So, in addition to announcing the great SYCHRONIZE-1 data we also revealed the MoA for the triple agonist We will potentially have the first-in-class triple GLP-1/GIP/NPY2 receptor agonist, single molecule Stay tuned for more updates and opportunities to join the team We will be building up Medical, Access and Marketing teams #Pharma #GLP1 #ObesityResearch #NextGenTherapeutics #JoinOurTeam #Hiring

Bariatric surgery or GLP-1 medication may help patients lose weight

Heres an in-depth look at